Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team
Analyst Comment

Qlife: Wrap up latest news

By Claus ThestrupCEO, Sweden
Qlife Holding

Qlife - wrap up latest news 

The company carried out a rights issue back in May 2023 with gross proceeds of SEK 57,7 mio. Last week their announced a convertible loan agreement of SEK 4,6 mio. Qlife have by that secured financing for 2023. On the cost side they announced back in June 2023 the termination of lease agreement for the Lab- and Headquarter in Ballerup with full impact from 1st. of November 2023 and a value of SEK 7,3 mio.

Read full announcement on loan terms here: Convertible loan

To further speed up the revenue, Qlife launched an open system called "Egoo Innovate". They presented this concept on the AACC (American Association for Clinical Chemistry) in Anaheim California the 23-27 of July. With Egoo Innovate - Hospital labs, CRO's and Pharma companies can test their biomarkers on the Egoo System to facilitate "At Home Testing". Senior management attended the conference in USA.

Read full announcement on Egoo Innovate here: Egoo Innovate

Disclaimer:

HC Andersen Capital receives payment from Qlife for a Digital IR/Corporate Visibility subscription agreement. /Claus Thestrup 08:25 AM 07-08-2023.

Qlife Holding AB is a med-tech group that strives to revolutionize the market for clinical biomarkers and virus tests. By enabling tests at home as a complement to tests in healthcare, access to important health information is facilitated, which can contribute to better treatment and potentially prevent diseases. The first capsules in the company's product, Egoo.Health Platform, were CE-marked for professional use in early 2020. The company has patent protection for key parts of its technology. The Danish-based company is listed on Nasdaq First North Stockholm.

Read more on company page
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.